- Argentina
- Australia
- Austria
- Bangladesh
- Belgium
- Botswana
- Brazil
- Bulgaria
- Canada
- Chile
- China
- Colombia
- Cuba
- Czech Republic
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Germany
- Ghana
- Greece
- Hong Kong
- Hungary
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Kenya
- Latvia
- Lebanon
- Lithuania
- Malaysia
- Mexico
- Morocco
- Namibia
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Senegal
- Singapore
- Slovakia
- Slovenia
- South Africa
- South Korea
- Spain
- Sweden
- Switzerland
- Taiwan
- Tanzania
- Thailand
- Turkey
- Uganda
- Ukraine
- United Arab Emirates
- United Kingdom
- United States
- Venezuela
- Vietnam
- Zimbabwe
Israel Health News API
Get the live top health headlines from Israel with our JSON API.
Get API key for the Israel Health News APIAPI Demonstration
This example demonstrates the HTTP request to make and the JSON response you will receive when you use the news api to get the top headlines from Israel.
GET
https://gnews.io/api/v4/top-headlines?country=il&category=health&apikey=API_KEY
{
"totalArticles": 11960,
"articles": [
{
"id": "d21cae579d98c41817cfc50cb2961419",
"title": "Randomized trial finds that oxybutynin reduces hot flashes during prostate cancer treatment",
"description": "A trial has found that oxybutynin reduces hot flashes compared to the placebo in men receiving hormone therapy for prostate cancer.",
"content": "Original story from Alliance for Clinical Trials in Oncology\nA national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder symptoms, reduces hot flashes compared... [2645 chars]",
"url": "https://www.oncology-central.com/randomized-trial-finds-that-oxybutynin-reduces-hot-flashes-during-prostate-cancer-treatment/",
"image": "https://www.oncology-central.com/wp-content/uploads/2026/02/Oncology-central-feature-image-8.png",
"publishedAt": "2026-02-04T07:35:47Z",
"lang": "en",
"source": {
"id": "8c808e3298c26ec63e1570c02b4191eb",
"name": "Oncology Central",
"url": "https://www.oncology-central.com"
}
},
{
"id": "0a35c20e83513a0f581efff6eb2b6712",
"title": "Bacterial Ecology and Resistance Profiles from Cheikh Ahmadoul Khadim National Hospital of Touba",
"description": "Background: Antimicrobial resistance (AMR) is a growing concern in sub-Saharan Africa, where infectious diseases remain highly prevalent. In Senegal, available AMR data are limited and fragmented. Methods: We conducted a retrospective study at Cheikh Ahmadoul Khadim National Hospital, Touba (January-December 2024). All hospitalized patients with culture-confirmed bacterial infections were included. Bacterial identification and antimicrobial susceptibility testing followed CA-SFM/EUCAST 2024 guidelines. Results: Among 369 patients (median age 36 years; 59% male), 251 cultures were positive (68%). Gram-negative bacilli predominated (69.5%), mainly Escherichia coli (24.2%) and Klebsiella spp. (22.1%). Gram-positive cocci accounted for 30%, dominated by Staphylococcus aureus (20.4%). Resistance to first-line antibiotics was high: penicillins ≈ 50%, third-generation cephalosporins 20% - 36% in Enterobacterales, and trimethoprim-sulfamethoxazole ≥ 37%. Carbapenem resistance remained low (Conclusion: AMR is widespread in Senegal, with ESBL-producing Enterobacterales and MRSA circulation. Strengthened surveillance and stewardship are urgently required.",
"content": "1. Introduction\nAntimicrobial resistance (AMR) has emerged as a major threat to public health, with considerable clinical and economic consequences. In 2019, nearly 5 million deaths were estimated to be associated with antibiotic-resistant infections... [21421 chars]",
"url": "https://www.scirp.org/journal/paperinformation?paperid=149393",
"image": "https://file.scirp.org/image/aid2016062314370904.jpg",
"publishedAt": "2026-02-04T07:35:39Z",
"lang": "en",
"source": {
"id": "48f641eab3fd1aa330e8db4cb1cfe74e",
"name": "SCIRP Open Access",
"url": "https://www.scirp.org"
}
},
{
"id": "50f2b3fcd572c7f444d59aefd4f859e9",
"title": "Abu Dhabi scientists test precision treatment to boost pancreatic cancer survival rates",
"description": "On World Cancer Day, researchers highlight potential way to tackle deadly form of disease",
"content": "Researchers in Abu Dhabi have used tiny light-sensitive nanoparticles to destroy pancreatic cancer cells in mice, an approach that they hope could eventually be used to treat people.\nWhile the method’s possible use in humans is a long way off, the re... [4343 chars]",
"url": "https://www.thenationalnews.com/news/uae/2026/02/04/abu-dhabi-scientists-test-precision-treatment-to-boost-pancreatic-cancer-survival-rates/",
"image": "https://www.thenationalnews.com/resizer/v2/LDTOPX6LTZCNRPTETJQWOII55E.jpg?smart=true&auth=8cb7d221b150cbd05c4439336ffac5fb56d7e6a3eba7a277b3329e6fa92a4892&width=1200&height=630",
"publishedAt": "2026-02-04T06:59:40Z",
"lang": "en",
"source": {
"id": "04ec576528ef8fb8bf622ecfb684f517",
"name": "thenationalnews.com",
"url": "https://www.thenationalnews.com"
}
}
]
}